Skip to main content
NeuMoDxNews Page

NeuMoDx Molecular Announces FDA 510(k) Clearance for its N288 Molecular System and GBS Assay

By August 8, 2018January 26th, 2022No Comments

NeuMoDx Molecular, a sample-to-result molecular diagnostic company focused on central laboratory customers, announced today it has received FDA 510(k) clearance for its NeuMoDx™ 288 Molecular System and its NeuMoDx™ GBS Assay.